TEVA PHARMACEUTICAL INDUSTRIES LTD company mark
Healthcare · NYSE/NASDAQ: TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD Annual Report 2026

AI-powered fundamental analysis, financial performance, quarterly earnings, management commentary, corporate governance, cash flow analysis and business intelligence for TEVA PHARMACEUTICAL INDUSTRIES LTD.

Drug Manufacturers - Specialty & Generic
Market Cap $39.23B
TEVA PHARMACEUTICAL INDUSTRIES LTD company mark

TEVA PHARMACEUTICAL INDUSTRIES LTD Annual Report 2026

Official Filings · AI Report coming soon
Official Annual + Quarterly Filings
NASDAQ/NYSE: TEVA
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Cap $39.23B
Source: SEC EDGAR
Business Intelligence Report
Not generated yet

Quality Scores

Business
Compounder
Management
Governance
Cash Flow
AI Quality Scores locked
Sign In to Generate One →

Latest Quarterly Earnings Summary

No quarterly summary yet

Generate the Business Intelligence Report to unlock AI earnings summary.

Sign In to Generate One →
Loading latest Annual Report…

TEVA PHARMACEUTICAL INDUSTRIES LTD Business Intelligence Hub

The TEVA PHARMACEUTICAL INDUSTRIES LTD Business Intelligence Hub is your central gateway to AI-powered company research, fundamental analysis, and equity research on TEVA PHARMACEUTICAL INDUSTRIES LTD. This page always opens the latest Business Intelligence annual report and stays in sync with TEVA PHARMACEUTICAL INDUSTRIES LTD's newest 10-K filings, quarterly results and management commentary — so you're never reading stale analysis.

TEVA PHARMACEUTICAL INDUSTRIES LTD Financial Performance & Statements

Explore TEVA PHARMACEUTICAL INDUSTRIES LTD's financial statements, revenue growth, net profit, EPS, book value, free cash flow and net worth trends over 5 and 10 years — with deterministic AI-validated numbers, not hallucinated summaries.

TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Earnings & Management Commentary

Read the latest TEVA PHARMACEUTICAL INDUSTRIES LTD quarterly results, earnings summary, management commentary and concall highlights — cross-checked against the official filing.

TEVA PHARMACEUTICAL INDUSTRIES LTD Growth, Governance & Cash Flow Analysis

AI-graded scores on business compounding, compounder quality, management credibility, corporate governance and cash flow strength — the pillars of long-term business quality.

TEVA PHARMACEUTICAL INDUSTRIES LTD Sector, Valuation & Risk Analysis

See TEVA PHARMACEUTICAL INDUSTRIES LTD in context: sector analysis, industry analysis, competitive position, capital allocation, valuation context and key risks — surfaced from a decade of annual reports.

Related searches: TEVA PHARMACEUTICAL INDUSTRIES LTD annual report, TEVA PHARMACEUTICAL INDUSTRIES LTD AI annual report, TEVA PHARMACEUTICAL INDUSTRIES LTD fundamental analysis, TEVA PHARMACEUTICAL INDUSTRIES LTD business analysis, TEVA PHARMACEUTICAL INDUSTRIES LTD financial performance, TEVA PHARMACEUTICAL INDUSTRIES LTD financial statements, TEVA PHARMACEUTICAL INDUSTRIES LTD growth analysis, TEVA PHARMACEUTICAL INDUSTRIES LTD management analysis, TEVA PHARMACEUTICAL INDUSTRIES LTD corporate governance, TEVA PHARMACEUTICAL INDUSTRIES LTD cash flow analysis, TEVA PHARMACEUTICAL INDUSTRIES LTD business intelligence, TEVA PHARMACEUTICAL INDUSTRIES LTD valuation, TEVA PHARMACEUTICAL INDUSTRIES LTD quarterly results, TEVA PHARMACEUTICAL INDUSTRIES LTD earnings summary, TEVA PHARMACEUTICAL INDUSTRIES LTD management commentary, TEVA PHARMACEUTICAL INDUSTRIES LTD sector analysis, TEVA PHARMACEUTICAL INDUSTRIES LTD company research, TEVA PHARMACEUTICAL INDUSTRIES LTD equity research, TEVA PHARMACEUTICAL INDUSTRIES LTD stock analysis, TEVA PHARMACEUTICAL INDUSTRIES LTD AI company analysis, TEVA PHARMACEUTICAL INDUSTRIES LTD capital allocation, TEVA PHARMACEUTICAL INDUSTRIES LTD risk analysis, TEVA PHARMACEUTICAL INDUSTRIES LTD competitive position, TEVA PHARMACEUTICAL INDUSTRIES LTD long-term growth.